Dierdre Connelly, GlaxoSmithKline’s top executive in North America, and several other high-profile executives headline the program for the Council of Entrepreneurial Development’s annual biotechnology conference.
Biotech Life Science 2011 is set for Feb. 21 and 22 in Raleigh. Registration is open.
Connelly’s title is president, North American Pharmaceuticals. GSK (NYSE: GSK) operates its U.S. headquarters in Research Triangle Park.
Other speakers include:
• David King, chairman and CEO of Burlington-based LabCorp.
• David Mott, former CEO of MedImmune who now is a general partner at venture capital firm NEA
• Lawrence Stern, chairman and CEO of RTP-based Talecris Biotherapeutics
• Robert Cascella, CEO of Hologic
For more information about the conference, read here.
Get the latest news alerts: Follow LTW at Twitter.